Share & more
People living with HIV/AIDS in Zambia could soon benefit from the local manufacture of anti-AIDS drugs.
PHARCO, a pharmaceutical firm partly owned by the government, announced that it was ready to begin a three-month drug trial on 28 HIV-positive volunteers.
A senior PHARCO employee said the firm would start full production of antiretroviral drugs once the trials had ended successfully.
A local newspaper, the Daily Mail, quoted PHARCO general manager Johan Richter as saying: "The plant will be able to produce a quantity of at least 150,000 treatments per year. Production capacity will be increased when and if required."
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions